To compare and evaluate the diagnostic performance of OCT-angiography (OCT-A) parameters in diabetic retinopathy (DR) detection compared to fluorescein angiography (FA).
Methods
This is a cross-sectional, prospective study including 118 diabetic patients (214 eyes). All patients had a complete clinical examination with FA as well as macular OCT-A imaging (3 × 3 mm, 6 × 6 mm). We compared the detection of fundamental DR lesions using both imaging modalities and assessed the diagnostic value of different OCT-A parameters.
Results
Microaneurysms were more frequently detected by FA than with OCT-A. Intraretinal microvascular anomalies were equally visualized by OCT-A (0.27 ± 0.777) and FA (0.27 ± 0.71). Average of foveal avascular zone (FAZ) surface was less significant at superficial capillary plexus (SCP) (0.353 ± 0.107 mm²) compared to deep capillary plexus (DCP) (0.537 ± 0,135 mm²), (p < 0.001). FAZ remodeling was observed even in DR free eyes and was better identified in DCP (61.1%) than SCP (47.2%). Loss of FAZ circularity was estimated at 0.792 ± 0.081 and 0.741 ± 0.107 respectively in SCP and DCP, (p < 0.001). Average surface area of capillary non-perfusion zones (CNPZ) was 0.487 ± 0.514 mm² in SCP and 0.145 ± 0.223 mm² in DCP, (p < 0.001). The Most reliable OCT-A quantitative parameters for DR screening were: CNPZ surface in DCP (p = 0.0046), total vascular density (VDt) in the DCP (p = 0.003) and CNPZ surface in the SCP (p = 0.0027).
Conclusion
OCT-A enables diabetic microvascular abnormalities detection even at a preclinical stage. Certain OCT-A parameters may provide a valuable quantitative approach for diagnosis and grading of DR severity.
LeeRWongTYSabanayagamC. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond)30 Sept 2015; 2: 17.
3.
KahlounRJellitiBZaoualiS, et al.Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye (Lond)Août 2014; 28: 986–991.
4.
MohamedQGilliesMCWongTY. Management of diabetic retinopathy: a systematic review. JAMA22 Août 2007; 298: 902–916.
5.
WilkinsonCPFerrisFLKleinRE, et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. OphthalmologySept 2003; 110: 1677–1682.
6.
Lecleire-ColletAErginayAMassinP. The diagnosis of diabetic retinopathy. Sang Thrombose Vaisseaux1 Oct 2008; 20: 431–434.
7.
de CarloTEChinATBonini FilhoMA, et al.Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography. RetinaNov 2015; 35: 2364–2370.
8.
Frequency of adverse systemic reactions after fluorescein angiography: Results of a prospective study. PubMed [Internet]. Disponible sur: https://pubmed.ncbi.nlm.nih.gov/1891225/
9.
AkilHKarstSHeislerM, et al.Application of optical coherence tomography angiography in diabetic retinopathy: a comprehensive review. Can J OphthalmolOct 2019; 54: 519–528.
10.
BattistaMBorrelliESacconiR, et al.Optical coherence tomography angiography in diabetes: a review. Eur J OphthalmolMai 2020; 30: 411–416.
11.
DsTGcCTyW. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clinical & experimental ophthalmology [Internet]mai 2016 [cité 21 juill 2024]; 44. Disponible sur. https://pubmed.ncbi.nlm.nih.gov/26716602/
12.
JiaYMorrisonJCTokayerJ, et al.Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express7 Nov 2012; 3: 3127–3137.
13.
JalliPYHellstedtTJImmonenIJ. Early versus late staining of microaneurysms in fluorescein angiography. Retina1997; 17: 211–215.
14.
CouturierAManéVBonninS, et al.Capillary Plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. RetinaNov 2015; 35: 2384–2391.
15.
SoaresMNevesCMarquesIP, et al.Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. Janv 2017; 101: 62–68.
16.
EndersCBaeuerleFLangGE, et al.Comparison between findings in optical coherence tomography angiography and in fluorescein angiography in patients with diabetic retinopathy. Ophthalmologica2020; 243: 21–26.
17.
SalzDAde CarloTEAdhiM, et al.Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes. JAMA Ophthalmol1 Juin 2016; 134: 644–650.
18.
HwangTSGaoSSLiuL, et al.Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA OphthalmolAvr 2016; 134: 367–373.
19.
MiwaYMurakamiTSuzumaK, et al.Relationship between functional and structural changes in diabetic vessels in optical coherence tomography angiography. Sci Rep28 Juin 2016; 6: 29064.
20.
HamadaMOhkoshiKInagakiK, et al.Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images. Jpn J OphthalmolMars 2018; 62: 168–175.
21.
ArendOWolfSJungF, et al.Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J OphthalmolSept 1991; 75: 514–518.
22.
TokayerJJiaYDhallaAH, et al.Blood flow velocity quantification using split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Biomed Opt Express2013; 4: 1909–1924.
23.
ParkJJSoetiknoBTFawziAA. Characterization of the middle capillary Plexus using optical coherence tomography angiography in healthy and diabetic eyes. RetinaNov 2016; 36: 2039–2050.
24.
CaoDYangDHuangZ, et al.Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy. Acta DiabetolMai 2018; 55: 469–477.
25.
ChoiWWaheedNKMoultEM, et al.Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina. Janv 2017; 37: 11–21.
26.
VerittiDSaraoVFrancescuttiL, et al.Optical coherence tomography angiography findings in diabetic retinopathy. Expert Rev Ophthalmol20 Oct 2017; 12.
27.
PanJChenDYangX, et al.Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography. Am J OphthalmolAoût 2018; 192: 146–156.
28.
SchaalKBMunkMRWyssmuellerI, et al.Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging. RetinaJanv 2019; 39: 79–87.
29.
VujosevicSMuracaAAlkabesM, et al.Early microvascular and neural changes in patients with type 1 and type 2 diabetes Mellitus without clinical signs of diabetic retinopathy. RetinaMars 2019; 39: 435–445.
30.
LeeHLeeMChungH, et al.Quantification of retinal vessel tortuosity in diabetic retinopathy using optical coherence tomography angiography. Retina. Mai 2018; 38: 976–985.
31.
SambhavKAbu-AmeroKKChalamKV. Deep capillary macular perfusion indices obtained with OCT angiography correlate with degree of nonproliferative diabetic retinopathy. Eur J Ophthalmol8 Nov 2017; 27: 716–729.
32.
VujosevicSTomaCVillaniE, et al.Early detection of microvascular changes in patients with diabetes Mellitus without and with diabetic retinopathy: comparison between different swept-source OCT-A instruments. J Diabetes Res12 Juin 2019; 2019: 2547216.
33.
KrawitzBDMoSGeymanLS, et al.Acircularity index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls measured by optical coherence tomography angiography. Vision ResOct 2017; 139: 177–186.
34.
GoudotMMSikoravASemounO, et al.Parafoveal OCT angiography features in diabetic patients without clinical diabetic retinopathy: a qualitative and quantitative analysis. J Ophthalmol2017; 2017: 8676091.
35.
IshibazawaANagaokaTTakahashiA, et al.Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J OphthalmolJuill 2015; 160: 35–44.e1.
36.
NesperPLRobertsPKOnishiAC, et al.Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis SciMai 2017; 58: BIO307–15.
37.
HwangTSHagagAMWangJ, et al.Automated quantification of nonperfusion areas in 3 vascular plexuses with optical coherence tomography angiography in eyes of patients with diabetes. JAMA Ophthalmol1 Août 2018; 136: 929–936.
38.
DurbinMKAnLShemonskiND, et al.Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol1 Avr 2017; 135: 370–376.
